Ann: PNV 4 New Patents, page-2

ASX Announcement PolyNovo four new patents in NovoSorb® IP expansion

PolyNovo is pleased to announce earlier this week the granting of four new Australian patents within the NovoSorb polymer family. These patents are relevant to our Hernia and Breast products however they also afford cover for other new devices we are planning to develop in the near term. Long term IP protection allows PolyNovo the ability to develop other unique products with sustainable competitive advantage.

The new patents are:

• 2018403989 Oriented biodegradable polyurethanes
o This assist with the design of products that may stretch/rebound in only one direction or have different characteristics to address the movement needs of various areas of the body in which devices will be placed.

• 2018390992 Tissue repair laminates
o For use in a non-adherent hernia repair device and other applications. The NovoSorb polymer has a very low adherent property.
One application is the NovoSorb extruded film that can be placed in the peritoneal cavity for hernia repair with minimal risk of creating bowel adhesion.

• 2018390991 Soft tissue implant pocket
o For use in covering other devices/ implants to encourage tissue ingrowth and address potential “dead spaces”. This can be extremely useful in breast surgery and other areas where a bulky device may need to be implanted into the body.

• 2018387125 Tissue repair laminates
o Application for use in a hernia device and other applications where tissue grows into both sides of the device. Enabling organised tissue regeneration either side of a device holds a lot of promise in reconstructive surgery where there has been significant excision, tissue loss or trauma.

PolyNovo’s CEO, Mr Paul Brennan said, “Our IP expansion program is a central part of our strategy to secure our long-term future as a manufacturer of unique, innovative and disruptive medical devices. These four new patents will provide the Company’s new and existing products with a strong and sustainable competitive advantage.” This announcement has been authorised by Company Secretary Jan-Marcel Gielen.

Pretty good Ann with diversification, well done PNV.